Comparative RNA quantification of HIV-1 group M and Non-M with the roche cobas ampliprep/cobas taqman HIV-1 v2.0 and abbott real-time HIV-1 PCR assays

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 3, 2011, Pages 239-243

  Sire, Jean Marie ^a   Vray, Muriel ^b   Merzouk, Mourad ^a   Plantier, Jean Christophe ^c   Pavie, Juliette ^d   Maylin, Sarah ^a   Timsit, Julie ^e   Lascoux Combe, Caroline ^a   Molina, Jean Michel ^d   Simon, François ^a   Delaugerre, Constance ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Service des Maladies Sexuellement Transmissibles   (France)

Author keywords

group O; group P; HIV 1 diversity; real time PCR; RNA quantification

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD SAMPLING; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; VIRUS LOAD; VIRUS STRAIN; VIRUS TYPING;

HIV-1; HUMANS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; VIRAL LOAD;

EID: 79951814335     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182099891     Document Type: Article

References (19)

1. Semaille C, Barin F, Cazein F, et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. J Infect Dis. 2007;196: 377-383. (Pubitemid 47093888)
2. Chaix ML, Descamps D, Wirden M, et al. Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France. AIDS. 2009;23:717-724.
3. Frange P, Galimand J, Vidal N, et al. New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: the French ANRS CO06 primo cohort study. Retrovirology. 2008; 5:69.
4. Vessiere A, Leoz M, Brodard V, et al. First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon. AIDS. 2010;24: 1079-1082.
5. Plantier JC, Leoz M, Dickerson JE, et al. A new human immunodeficiency virus derived from gorillas. Nat Med. 2009;15:871-872.
6. Delaugerre C, Denis B, Peytavin G, et al. Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient. J Clin Microbiol. 2009;47:3763-3764.
7. Gueudin M, Plantier JC, Lemee V, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr. 2007;44:500-505. (Pubitemid 46594892)
8. Wirden M, Tubiana R, Marguet F, et al. Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. J Clin Microbiol. 2009;47:1543-1545.
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310. (Pubitemid 16134762)
10. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, .2009. Available at: http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf. Accessed July 12, 2010.
11. Yeni P. Prise en Charge Médicale des Personnes Infectées Par le VIH. La Documentation Francxaise. Paris, France; 2008.
12. Damond F, Avettand-Fenoel V, Collin G, et al. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J Clin Microbiol. 2010;48:1413-1416.
13. De Bel A, Marissens D, Debaisieux L, et al. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay. J Clin Microbiol. 2010;48:1337-1342.
14. Scott L, Carmona S, Stevens W. Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay. J Clin Microbiol. 2009;47:3400-3402.
15. Pas S, Rossen JW, Schoener D, et al. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol. 2010;48:1195-1200.
16. Lima V, Harrigan R, Montaner JS. Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay. J Acquir Immune Defic Syndr. 2009;51:3-6.
17. Rebeiro PF, Kheshti A, Bebawy SS, et al. Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures. Clin Infect Dis. 2008;47:1354-1357.
18. Garcia-Bujalance S, Ladron de Guevara C, Gonzalez-Garcia J, et al. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1. J Microbiol Methods. 2007;69:384-386. (Pubitemid 46551304)
19. Amiel C, Schneider V, Lescure FX, et al. Analysis of the impact of a raltegravir-containing regimen on HIV-1 RNA quantification by the Abbott RealTime HIV-1 assay. Paper presented at: 12th European AIDS Conference/EACS, 2009; Cologne, Germany.